Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results.
Business Wire › March 31, 2009
Linked as:
Business Wire › March 31, 2009
Linked as:Extract
Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results.
TEWKSBURY, Mass. -- Acusphere, Inc. (ACUS:PK) today reported financial results for the fourth quarter and year ended December 31, 2008, and commented on its business and progress to date. The Company continues to discuss its New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) for its lead product candidate, Imagify(TM) (Perflubutane Polymer Microspheres) for Injectable Suspension following the receipt of FDA's complete response letter in late February. Imagify is a Perfusion Stress Echo imaging agent targeted for use in detecting ...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
43 usc 1642 sec 1642 land conveyances | Secs 8711 to 8719 Omitted | USA vs. Green, (5th Cir. 1998) | US v Padgett 4th Cir 2003 | sentencia nº 2206 de consiglio di stato may 19 2010 | fuerte caída en accidentes por alcohol en 2012 | Sentencia nº 413 de Consiglio di Stato, January 25, 2008 | Sentencia nº 1380 de Consiglio di Stato March 25 2011